Stock Earnings

Question 1

Quels sont les états financiers clés de Zealand Pharma A/S ?

Accepted Answer

Selon le dernier état financier (Form-10K), Zealand Pharma A/S a un total d'actifs de $9,505, un bénéfice net loss de $-1,078

Question 2

Quels sont les ratios financiers clés pour ZLDPF ?

Accepted Answer

Le ratio de liquidité de Zealand Pharma A/S est 10.7, la marge nette est -1,738.7, les ventes par action sont de $0.93.

Question 3

Comment les revenus de Zealand Pharma A/S sont-ils répartis par segment ou géographie ?

Accepted Answer

Zealand Pharma A/S largest revenue segment is Peptide-based Medicines, at a revenue of 62,691,000 in the most earnings release.For geography, Denmark is the primary market for Zealand Pharma A/S, at a revenue of 62,285,000.

Question 4

Zealand Pharma A/S est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Zealand Pharma A/S a un bénéfice net loss de $-1,078

Question 5

Zealand Pharma A/S a-t-elle des passifs ?

Accepted Answer

yes, Zealand Pharma A/S a un passif de 888

Question 6

Combien d'actions en circulation Zealand Pharma A/S a-t-elle ?

Accepted Answer

Zealand Pharma A/S a un total d'actions en circulation de 70.65

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	9,109	62	342	103	108	192
Revenue Growth (YoY)	2,382%	-82%	231.99%	-5%	-44%	368%
Cost of Revenue	-5	7	19	0	10	0
Gross Profit	9,115	54	323	103	97	192
Selling, General & Admin	461	397	190	263	293	212
Research & Development	1,271	900	666	590	561	581
Operating Expenses	1,736	1,323	884	879	879	794
Other Non Operating Income (Expenses)	-5	-6	-19	2	6	-4
Pretax Income	7,214	-1,083	-708	-972	-758	-673
Income Tax Expense	533	-4	-5	-6	-3	-4
Net Income	6,680	-1,078	-703	-1,202	-1,018	-846
Net Income Growth	-1,038%	53%	-42%	18%	20%	48%
Shares Outstanding (Diluted)	71.71	66.43	56.58	46.2	42.86	38.36
Shares Change (YoY)	14%	17%	22%	8%	12%	14%
EPS (Diluted)	93.16	-16.23	-12.43	-26.02	-23.75	-22.06
EPS Growth	-921%	31%	-52%	10%	8%	30%
Free Cash Flow	7,523	-943	-449	-954	-1,234	-713
Free Cash Flow Per Share	104.9	-14.19	-7.93	-20.64	-28.78	-18.58
Gross Margin	100.06%	87.09%	94.44%	100%	89.81%	100%
Operating Margin	81%	-2,046.77%	-164.03%	-752.42%	-724.07%	-313.54%
Profit Margin	73.33%	-1,738.7%	-205.55%	-1,166.99%	-942.59%	-440.62%
Free Cash Flow Margin	82.58%	-1,520.96%	-131.28%	-926.21%	-1,142.59%	-371.35%
EBITDA	7,403	-1,244	-536	-658	-742	-560
EBITDA Margin	81.27%	-2,006.45%	-156.72%	-638.83%	-687.03%	-291.66%
D&A For EBITDA	24	25	25	117	40	42
EBIT	7,379	-1,269	-561	-775	-782	-602
EBIT Margin	81%	-2,046.77%	-164.03%	-752.42%	-724.07%	-313.54%
Effective Tax Rate	7.38%	0.36%	0.7%	0.61%	0.39%	0.59%

Zealand Pharma A/S (ZLDPF) Price

ZLDPF Stock Price Chart

ZLDPF Income

Follow-Up Questions